IMRICOR MEDICAL SYSTEMS INC (IMR)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
IMR - IMRICOR MEDICAL SYSTEMS INC
FNArena Sector :
Medical Equipment & Devices
Year End: December
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.65
Index:
FNArena Sector : Medical Equipment & Devices
Year End: December
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.65
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.455
15 May |
0.000 OPEN $0.46 |
0.000 HIGH $0.46 |
0 LOW $0.46 |
TARGET | |||||
|
OTHER COMPANIES IN THE SAME SECTOR | |||
4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . IDX . IME . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . VTI . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY24 Forecast |
FY25 Forecast |
---|---|---|
EPS (cps) | - 10.7 | xxx |
DPS (cps) | 0.0 | xxx |
EPS Growth | N/A | xxx |
DPS Growth | N/A | xxx |
PE Ratio | N/A | xxx |
Dividend Yield | 0.0% | xxx |
Div Pay Ratio(%) | N/A | xxx |
All estimates have been converted into AUD by FNArena at present FX values.
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -21.8 |
DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 0.9 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | -7.6 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -19.6 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -3,675.61 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | - |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -386.76 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -210.55 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | - |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -247.69 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -19.7 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 2 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 14 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 16 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 1 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | - |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 0.1 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 13.45 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 3 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 24 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | 12 M |
Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
IMR STOCK CHART
FNArena News on IMR
1 |
Australian Broker Call *Extra* Edition – Aug 16, 2023Aug 16 2023 - Daily Market Reports |
2 |
Dr Boreham’s Crucible: Imricor Medical SystemsOct 17 2022 - Small Caps |
3 |
Australian Broker Call *Extra* Edition – Sep 14, 2022Sep 14 2022 - Daily Market Reports |
4 |
Australian Broker Call *Extra* Edition – Sep 13, 2022Sep 13 2022 - Daily Market Reports |
5 |
Australian Broker Call *Extra* Edition – Feb 03, 2022Feb 03 2022 - Daily Market Reports |
Latest Medical Equipment & Devices News
1 |
ResMed Silences The DoubtersApr 29 2024 - Australia |
2 |
Dr Boreham’s Crucible: 4D MedicalApr 23 2024 - Small Caps |
3 |
Uptrend Resumed For ResMedMar 19 2024 - Technicals |
4 |
Dr Boreham’s Crucible: CochlearFeb 28 2024 - Australia |
5 |
Rudi Interviewed: Ongoing Potential In Technology & GrowthFeb 19 2024 - Rudi's View |
6 |
Dr Boreham’s Crucible: ArtryaFeb 15 2024 - Small Caps |
7 |
ResMed Recovery Turns Into Hollywood ScriptJan 31 2024 - Australia |
8 |
ResMed Makes A ComebackJan 29 2024 - Australia |
9 |
ResMed: The Recovery Has BegunJan 23 2024 - Technicals |
10 |
Dr Boreham’s Crucible: Pro MedicusOct 23 2023 - Australia |